Wrist Denervation vs Exercise in Wrist Osteoarthritis

Sponsor
Karolinska Institutet (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06098586
Collaborator
(none)
140
2
48

Study Details

Study Description

Brief Summary

A randomized controlled trial comparing partial wrist denervation to a self-managed exercise therapy program in 140 patients with wrist osteoarthritis.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Self-managed exercise therapy program
  • Procedure: Partial wrist denervation
N/A

Detailed Description

Backgroud:

High quality evidence regarding the effectiveness of non-operative and operative treatments in wrist osteoarthritis are lacking.

Aim:
To analyze:
  1. Does partial wrist denervation and self-managed exercise therapy improve patient-reported outcomes, pain, grip strength and range of motion (ROM) in wrist OA?

  2. Is any of the two treatment concepts partial wrist denervation and self-managed exercise therapy more efficient than the other in terms of patient-reported outcomes, pain relief, grip strength and range of motion?

Method:

A multicenter parallel group, two-arm, randomized, controlled, assessor blinded, trial of 140 patients. The study is conducted at the departments of hand surgery at Södersjukhuset Stockholm and Malmö University hospital.

Group1:
Self-managed exercise therapy program containing:
  • Patient education:

  • Exercise therapy program:

The exercise therapy program is designed by Sara Larsson (physiotherapist at the Department of hand surgery in Malmö, Sweden), influenced by previous studies on wrist stability and proprioception. Focus is on functional re-learning and strengthening of the musculoskeletal system with the aim to create a stable wrist that can be used in a pain-free manner in activities of daily living. The program consists of neuromuscular exercises that focus on coordination, wrist stability and strength.

Group 2:

Surgery will be performed under local anesthesia (+ blood-less field or wide-awake local anesthesia no torniquet (WALANT) according to the surgeon's preference) through a single dorsal incision. AIN and PIN neurectomy will be performed as described by Berger (Berger, 1998).

Primary outcome:

Patient Rated Wrist Evaluation (PRWE) score (0-100) (MacDermid et al., 1998) 12 months after intervention.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
140 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Masking Description:
Data assessors and analysts will be masked for treatment allocation (covered wrist / anonymous data sheet).
Primary Purpose:
Treatment
Official Title:
Partial Wrist Denervation Versus Self-managed Exercise Therapy in Patients With Wrist Osteoarthritis: A Randomized Controlled Multicenter Trial
Anticipated Study Start Date :
Nov 15, 2023
Anticipated Primary Completion Date :
Nov 15, 2026
Anticipated Study Completion Date :
Nov 15, 2027

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Self-managed exercise therapy program

Exercise program focusing on functional re-learning and strengthening of the musculoskeletal system with the aim to create a stable wrist that can be used in a pain-free manner in activities of daily living.

Behavioral: Self-managed exercise therapy program
Exercise program focusing on functional re-learning and strengthening of the musculoskeletal system with the aim to create a stable wrist that can be used in a pain-free manner in activities of daily living.

Active Comparator: Partial wrist denervation

AIN and PIN neurectomy through a dorsal approach as described by Berger (Berger, 1998).

Procedure: Partial wrist denervation
AIN and PIN neurectomy through a dorsal approach as described by Berger (Berger, 1998).

Outcome Measures

Primary Outcome Measures

  1. PRWE [12 months]

    Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998)

Secondary Outcome Measures

  1. PRWE [3 months]

    Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998)

  2. PRWE [6 months]

    Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998)

  3. PRWE [5 years]

    Patient Rated Wrist Evaluation (PRWE) score (0-100 (high score worse outcome)) (MacDermid et al., 1998)

  4. Pain NRS [3 months]

    Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004)

  5. Pain NRS [6 months]

    Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004)

  6. Pain NRS [12 months]

    Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004)

  7. Pain NRS [5 years]

    Pain at rest and on load measured by a Numerical Rating Scale (NRS, 0-100 (higher score worse outcome) (Salaffi et al 2004)

  8. EQ5D [3 months]

    EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996)

  9. EQ5D [6 months]

    EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996)

  10. EQ5D [12 months]

    EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996)

  11. EQ5D [5 years]

    EQ-5D-5L (0-1 (higher score better outcome)) (Brooks, 1996)

  12. GROC [3 months]

    Global rating of change (GROC, -5-+5, higher score better outcome)

  13. GROC [6 months]

    Global rating of change (GROC, -5-+5, higher score better outcome)

  14. GROC [12 months]

    Global rating of change (GROC, -5-+5, higher score better outcome)

  15. GROC [5 years]

    Global rating of change (GROC, -5-+5, higher score better outcome)

  16. Pain catastrophizing [3 months]

    PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995)

  17. Pain catastrophizing [6 months]

    PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995)

  18. Pain catastrophizing [12 months]

    PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995)

  19. Pain catastrophizing [5 years]

    PCS (Pain catastrophizing scale, 0-52, higher score worse outcome) (Sullivan et al, 1995)

  20. ROM [3 months]

    Range of motion (ROM) of the wrist.

  21. ROM [6 months]

    Range of motion (ROM) of the wrist.

  22. ROM [12 months]

    Range of motion (ROM) of the wrist.

  23. ROM [5 years]

    Range of motion (ROM) of the wrist.

  24. Grip [3 months]

    Grip strength (Jamar).

  25. Grip [6 months]

    Grip strength (Jamar).

  26. Grip [12 months]

    Grip strength (Jamar).

  27. Grip [5 years]

    Grip strength (Jamar).

  28. Complications [3 months]

    Complications related to treatment

  29. Complications [6 months]

    Complications related to treatment

  30. Complications [12 months]

    Complications related to treatment

  31. Complications [5 years]

    Complications related to treatment

  32. Radiology [5 years]

    Radiological grade of osteoarthritis 5 years after inclusion compared to baseline.

  33. Cost [12 months]

    Differences in direct costs associated with treatment and indirect costs.

  34. sick leave [12 months]

    length of sick leave

  35. work [12 months]

    ability to return to previous work

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 years.

  • Chronic wrist pain (≥6 months) due to Scapholunate advanced collapse (SLAC) / Scaphoid non-union advanced collapse (SNAC) grade 1-3 osteoarthritis.

  • Radiological signs of osteoarthritis on posteroanterior and lateral radiograph.

Exclusion Criteria:
  • Previous PIN or AIN neurectomy.

  • Rheumatoid arthritis or other chronic inflammatory arthritis.

  • Symptomatic osteoarthritis in the distal radio-ulnar (DRU), Scapho-trapezio-trapezoid (STT) or thumb carpometacarpal (CMC) joints.

  • Ongoing infection.

  • Inability to co-operate with the follow-up protocol.

  • Systemic or intra-articular glucocorticoids or intraarticular PRP or Hyaluronic acid injections in the affected joint within 3 months prior to enrollment.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Karolinska Institutet

Investigators

  • Principal Investigator: Elin Swärd, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Elin Swärd, Principal Investigator, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT06098586
Other Study ID Numbers:
  • 2023-04885-01
First Posted:
Oct 24, 2023
Last Update Posted:
Oct 26, 2023
Last Verified:
Oct 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 26, 2023